Ownership history in Boxer Capital, LLC · 14 quarters on record
This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | UNCHANGED | 1,726,000 | — | 0% | 2.44% | $49.8M | $31.91 |
| 2024 Q3 | UNCHANGED | 1,726,000 | — | 0% | 2.44% | $49.8M | $28.84 |
| 2024 Q2 | UNCHANGED | 1,726,000 | — | 0% | 3.49% | $66.2M | $38.36 |
| 2024 Q1 | UNCHANGED | 1,726,000 | — | 0% | 5.01% | $101.5M | $58.78 |
| 2023 Q4 | UNCHANGED | 1,726,000 | — | 0% | 5.15% | $103.3M | $59.86 |
| 2023 Q3 | ADDED | 1,726,000 | +150,000 | +9.5% | 3.50% | $65.7M | $38.04 |
| 2023 Q2 | UNCHANGED | 1,576,000 | — | 0% | 6.66% | $143.6M | $91.10 |
| 2023 Q1 | UNCHANGED | 1,576,000 | — | 0% | 5.11% | $104.0M | $65.96 |
| 2022 Q4 | ADDED | 1,576,000 | +272,300 | +20.9% | 4.30% | $81.5M | $51.71 |
| 2022 Q3 | UNCHANGED | 1,303,700 | — | 0% | 5.01% | $89.0M | $68.30 |
As of 2025 Q4 — sorted by position size